Your browser doesn't support javascript.
loading
CCL23 suppresses liver cancer progression through the CCR1/AKT/ESR1 feedback loop.
Meng, Jin; Wang, Lianghai; Hou, Jun; Yang, Xiaofeng; Lin, Ke; Nan, Hongxing; Li, Man; Wu, Xiangwei; Chen, Xueling.
Afiliação
  • Meng J; Key Laboratory of Xinjiang Endemic and Ethnic Diseases/The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, China.
  • Wang L; Key Laboratory of Xinjiang Endemic and Ethnic Diseases/The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, China.
  • Hou J; NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, China.
  • Yang X; Key Laboratory of Xinjiang Endemic and Ethnic Diseases/The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, China.
  • Lin K; NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, China.
  • Nan H; Key Laboratory of Xinjiang Endemic and Ethnic Diseases/The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, China.
  • Li M; Key Laboratory of Xinjiang Endemic and Ethnic Diseases/The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, China.
  • Wu X; Key Laboratory of Xinjiang Endemic and Ethnic Diseases/The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, China.
  • Chen X; Key Laboratory of Xinjiang Endemic and Ethnic Diseases/The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, China.
Cancer Sci ; 112(8): 3099-3110, 2021 Aug.
Article em En | MEDLINE | ID: mdl-34050704

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulação para Baixo / Quimiocinas CC / Receptor alfa de Estrogênio / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulação para Baixo / Quimiocinas CC / Receptor alfa de Estrogênio / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido